1Lattice Logo

1Lattice Insights

We harness the collective power of data, networks, and technology to disrupt business decisions.

All Insights
What should investors check in AI due diligence?Financial Investors29 Oct 2026

What should investors check in AI due diligence?

Impressive AI isn’t the same as investable AI. 1Lattice merket intelligence platform shows how investors can move from management claims to real conviction. The question is whether the underlying technology creates reliable customer outcomes, attractive economics and an advantage that can endure.

Read More
An interesting time for jewelry brands in a glittering marketRetail26 Oct 2026

An interesting time for jewelry brands in a glittering market

Gold prices are reshaping how India buys jewelry. 1Lattice looks at why frequency, new occasions and trust now matter more than ticket size. As gold gets more expensive, jewellery brands have an opportunity to grow by creating more relevant reasons to buy, without compromising the trust that underpins the category.

Read More
How did CPCB IV+ emission norms change India’s genset market?Industrial Goods & Services23 Oct 2026

How did CPCB IV+ emission norms change India’s genset market?

CPCB IV+ is usually read as a cost shock for genset makers. A closer look suggests something different. The norm raised revenue per kVA, concentrated market share among larger players, and quietly gave Indian manufacturers an export asset. For OEM strategists and investors, the real question isn’t whether compliance was expensive. It’s who came out ahead.

Read More
Kusumgar's IPO: How India's engineered fabrics market is creating a higher-value textile opportunityRetail15 Oct 2026

Kusumgar's IPO: How India's engineered fabrics market is creating a higher-value textile opportunity

Kusumgar's IPO puts India's engineered fabrics market in focus. 1Lattice explains the four shifts behind its growth and what investors look for in companies preparing to go public.

Read More
Beyond the score: What your NPS is actually telling youRetail13 Oct 2026

Beyond the score: What your NPS is actually telling you

Same NPS, different businesses. 1Lattice explains the five questions behind your score and how driver analysis turns NPS into clear action.

Read More
1Lattice ECM Pulse, September 2026: Broad IPO participation, concentrated mainboard capitalBusiness and Professional Services13 Oct 2026

1Lattice ECM Pulse, September 2026: Broad IPO participation, concentrated mainboard capital

September 2026 brought 70 IPO listings in India. 1Lattice ECM Pulse looks at why mainboard capital concentrated in a few large issues while SME activity stayed broad-based.

Read More
India’s IVD market: How instruments, reagents and diagnostic networks are shaping growthHealthcare06 Oct 2026

India’s IVD market: How instruments, reagents and diagnostic networks are shaping growth

India’s in vitro diagnostics (IVD) market is evolving as diagnostic testing expands and competition shifts across instruments, platforms and reagents. This insight examines the economics of instrument placements, recurring reagent demand, key diagnostic segments and changing competitive dynamics.

Read More
Orient Cables’ IPO: The physical infrastructure behind India’s digital connectivity boomRetail04 Oct 2026

Orient Cables’ IPO: The physical infrastructure behind India’s digital connectivity boom

India’s broadband-cables market is projected to more than double by FY31P, driven by fibreization, 5G, data centres and enterprise digitisation, while product capability, certification, customer access and manufacturing scale become increasingly important.

Read More
AceVector’s IPO: India’s digital commerce opportunity is broadening beyond the marketplaceRetail04 Oct 2026

AceVector’s IPO: India’s digital commerce opportunity is broadening beyond the marketplace

India’s digital commerce opportunity is broadening beyond marketplaces as value-led consumption, seller complexity, commerce technology, and digital brands create new growth pools.

Read More
Molbio Diagnostics’ IPO: What India’s molecular POCT transformation means for growthHealthcare28 Sep 2026

Molbio Diagnostics’ IPO: What India’s molecular POCT transformation means for growth

India’s molecular point-of-care testing market is expanding beyond respiratory infections. With the market projected to reach INR 152.1B by FY31P, broader disease coverage, decentralized testing, multi-disease platforms, and new adoption pathways are reshaping the opportunity.

Read More
India’s MedTech procurement is changing: What matters for GTM?Pharma28 Sep 2026

India’s MedTech procurement is changing: What matters for GTM?

India’s MedTech procurement landscape is expanding, but the opportunity is increasingly shaped by how procurement happens, where demand is emerging, and what each tender requires beyond the initial equipment purchase.

Read More
India’s data center outlook: What does it mean for genset demand?Industrial Goods & Services21 Sep 2026

India’s data center outlook: What does it mean for genset demand?

India’s data center capacity could reach 4–12 GW by 2030, with AI workload growth driving much of the uncertainty. But does the genset opportunity change significantly across these scenarios?

Read More
Showing 1–12 of 317 insights
…